Reportedly, healthcare giant Johnson & Johnson (JNJ) to continue selling its talc-based Johnson’s Baby Powder in the UK and the rest of the world, after facing ban in the US and Canada.
The component talc which is mined from the earth and is found close to that of asbestos, known to cause cancer and the company has been at the centre of claims for years stating that its talc causes cancer.
The company said in a statement: “Johnson & Johnson remains steadfastly confident in the safety of talc-based Johnson’s Baby Powder.”
The company to sell its talc-based products in the US and Canada until stocks last and it will continue to sell its cornstarch-based powder in North America. Both types of Johnson’s baby powder, talc-based and cornstarch-based, will be available in other markets around the world where there is high consumer demand for the product.
Dow 30 component Johnson & Johnson (JNJ) is a worldwide healthcare focused company that embraces research and science so that it can provide customers with innovative ideas, products, and services. To learn more about Johnson & Johnson (JNJ) and to continue to track its progress visit the Vista Partners Johnson & Johnson Coverage Page.
Vista Partners LLC (”Vista”) is a California Registered Investment Advisor based in San Francisco. Vista delivers timely and relevant insights via the website: www.vistapglobal.com with daily stories, weekly market updates, monthly macroeconomic newsletters, podcasts, & Vista’s proprietary equity and market research to help you stay informed and stay competitive. Vista’s mission is to invest partner capital while arming investors with a comprehensive global financial perspective across all market sectors. Vista also seeks to provide select issuers with actionable advice regarding fundamental development, corporate governance, and capital market directives.
Stay Informed! Stay Competitive! Please join us at Vista Partners and receive our FREE email updates throughout the week and view our exclusive content and research.